Key result
Anesthetic management in patients with hypertrophic cardiomyopathy requires careful selection of techniques to maintain preload, increase systemic vascular resistance, and avoid tachycardia.
Why the study?
Up to 60% of patients with hypertrophic cardiomyopathy experience postoperative cardiac issues such as myocardial infarction or congestive heart failure after surgery.
This review provides guidance on anesthetic technique selection for patients with hypertrophic cardiomyopathy undergoing noncardiac surgery.
Warrants tailored anesthesia in HCM to preserve hemodynamics; supports consensus yet leaves open randomized comparisons of techniques.
Hypertrophic cardiomyopathy (HCM) is a common hereditary cardiomyopathy that affects up to 1 in 200 people in the general population [1,2] Patients with HCM usually have asymmetric or isolated areas of left ventricular hypertrophy >15 mm that aren't caused by anything else. The majority of patients have left ventricular outflow tract (LVOT) blockage at rest or with provocation owing to systolic anterior motion (SAM) of the mitral valve with mitral-ventricular septal contact. In addition, SAM causes mild to moderate mitral regurgitation (MR), which is usually oriented posteriorly [3, 4]. Up to 60% of HCM patients experience cardiac issues after surgery (myocardial infarction (MI), congestive heart failure (CHF), or both) [5]. We will discuss anesthetic technique selection during noncardiac surgery for individuals with a preoperative diagnosis of HCM and provide some tips in this review.
No takes yet. Share an insight, caveat, or question.
Değirmenci et al. (2022) conducted a review in Hypertrophic Cardiomyopathy (HCM). Anesthetic techniques was evaluated. Anesthetic management in patients with hypertrophic cardiomyopathy requires careful selection of techniques to maintain preload, increase systemic vascular resistance, and avoid tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: